Douglas M. Fambrough, III
2019
In 2019, Douglas M. Fambrough, III earned a total compensation of $5M as President and Chief Executive Officer at Dicerna Pharmaceuticals, a 102% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $393,675 |
|---|---|
| Option Awards | $4,110,700 |
| Salary | $524,900 |
| Other | $18,858 |
| Total | $5,048,133 |
Fambrough received $4.1M in option awards, accounting for 81% of the total pay in 2019.
Fambrough also received $393.7K in non-equity incentive plan, $524.9K in salary and $18.9K in other compensation.
Rankings
In 2019, Douglas M. Fambrough, III's compensation ranked 2,170th out of 13,971 executives tracked by ExecPay. In other words, Fambrough earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,170 out of 13,971 | 85th |
Division Manufacturing | 788 out of 5,701 | 86th |
Major group Chemicals And Allied Products | 247 out of 2,200 | 89th |
Industry group Drugs | 199 out of 1,886 | 89th |
Industry Pharmaceutical Preparations | 146 out of 1,398 | 90th |
Source: SEC filing on April 22, 2020.
Fambrough's colleagues
We found four more compensation records of executives who worked with Douglas M. Fambrough, III at Dicerna Pharmaceuticals in 2019.